Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicasio Mancini

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Mbio|May 16, 2022
Monoclonal Antibodies and Flaviviruses: a Possible Option?Nicasio Mancini
European Urology|July 25, 2018
Analysis of the Enteric Microbiome: First Tentative Steps Towards a Comprehensive Work-up of Prostate Cancer?Ilaria Cavarretta, Nicasio Mancini, Andrea Salonia
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2014
Microbiological diagnosis of sepsis: the confounding effects of a "gold standard"Nicasio Mancini, Roberto Burioni, Massimo Clementi
The New England Journal of Medicine|August 31, 2012
Natalizumab-associated progressive multifocal leukoencephalopathyNicasio Mancini, Massimo Clementi, Roberto Burioni
Science Signaling|February 6, 2020
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplayNicasio Mancini, Francesco Peri, Maria Rescigno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2016
Rational Dosing Strategies of Colistin: What About Resistance?Nicasio Mancini, Nicola Clementi, Roberto Burioni, et al.
Viruses|December 4, 2012
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)Giuseppe Sautto, Nicasio Mancini, Massimo Clementi, et al.
Journal of Clinical Microbiology|October 18, 2013
Risks of "blind" automated identification systems in medical microbiologyNicasio Mancini, Roberto Burioni, Maurizio Sanguinetti, et al.
Journal of Hepatology|June 17, 2008
Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugsRoberto Burioni, Mario Perotti, Nicasio Mancini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 10, 2021
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospitalDavide Ferrari, Nicola Clementi, Nicasio Mancini, et al.
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Mbio|May 16, 2022
Monoclonal Antibodies and Flaviviruses: a Possible Option?Nicasio Mancini
European Urology|July 25, 2018
Analysis of the Enteric Microbiome: First Tentative Steps Towards a Comprehensive Work-up of Prostate Cancer?Ilaria Cavarretta, Nicasio Mancini, Andrea Salonia
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2014
Microbiological diagnosis of sepsis: the confounding effects of a "gold standard"Nicasio Mancini, Roberto Burioni, Massimo Clementi
The New England Journal of Medicine|August 31, 2012
Natalizumab-associated progressive multifocal leukoencephalopathyNicasio Mancini, Massimo Clementi, Roberto Burioni
Science Signaling|February 6, 2020
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplayNicasio Mancini, Francesco Peri, Maria Rescigno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2016
Rational Dosing Strategies of Colistin: What About Resistance?Nicasio Mancini, Nicola Clementi, Roberto Burioni, et al.
Viruses|December 4, 2012
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)Giuseppe Sautto, Nicasio Mancini, Massimo Clementi, et al.
Journal of Clinical Microbiology|October 18, 2013
Risks of "blind" automated identification systems in medical microbiologyNicasio Mancini, Roberto Burioni, Maurizio Sanguinetti, et al.
Journal of Hepatology|June 17, 2008
Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugsRoberto Burioni, Mario Perotti, Nicasio Mancini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 10, 2021
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospitalDavide Ferrari, Nicola Clementi, Nicasio Mancini, et al.
Pageof 17